Skip to main content
TipRanks
Go Ultimate75% OFF

Taiwan Hopax Chemicals Manufacturing Co. Ltd. (6509) AI Stock Analysis

TW:6509

Taiwan Hopax Chemicals Manufacturing Co. Ltd.

(TPEx:6509)

Select Model
Rating:72Outperform
Price Target:TWD 51.00â–²(18.06% Upside)
Action:initiatedcoverage
Date:11/09/26

Strong financial performance from margin expansion and lower leverage is the primary driver, supported by reasonable valuation. Short-term technical weakness from moving averages and MACD tempers the score but oversold conditions limit further downside risk.

Positive Factors
Improving ProfitabilityImproved 2025 gross, EBITDA, and net margins indicate stronger profitability in the specialty-chemicals business. If these levels persist, they can provide more internal funding for operations and investment while improving resilience when downstream demand fluctuates.
Negative Factors
Sharp Revenue ContractionThe sharp 2025 revenue contraction shows that demand is sensitive to business cycles and downstream manufacturing conditions. Such volatility can undermine the durability of recent earnings gains, weaken operating leverage, and make future planning and resource allocation less predictable.

Taiwan Hopax Chemicals Manufacturing Co. Ltd. (6509) vs. SPDR S&P 500 ETF (SPY)

-20%0%20%40%60%80%TW:6509+34.33%SPY+14.28%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 9.09B
Dividend Yield
3.23%
Average Volume (3M)
887.52K
Price to Earnings (P/E)
13.0
Beta (1Y)
0.73
Revenue Growth
2.00%
EPS Growth
57.23%
Country
TW
Employees
891
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Taiwan Hopax Chemicals Manufacturing Co. Ltd. Business Overview & Revenue Model

Company Description

Taiwan Hopax Chemicals Manufacturing Co., Ltd. (Hopax) operates as a global manufacturer and supplier, specializing in a diverse array of chemical solutions. The company's core business encompasses the production and sale of specialty chemicals, fine...

Taiwan Hopax Chemicals Manufacturing Co. Ltd. Financial Statement Overview

Summary

Profitability strengthened with gross margins at 32.3% and net margins at 11.6%, balance sheet improved via deleveraging to debt-to-equity of 0.30, backed by solid operating cash flow of 1.22 billion.

Income Statement

76Positive

Balance Sheet

84Very Positive

Cash Flow

71Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue5.00B4.88B4.75B4.52B5.46B4.73B
Gross Profit1.75B1.58B1.45B1.26B1.51B1.32B
EBITDA1.32B1.11B995.96M869.08M1.08B865.80M
Net Income710.54M567.43M489.91M429.99M599.35M428.81M
Balance Sheet
Total Assets8.26B7.87B7.33B6.08B6.68B6.25B
Cash, Cash Equivalents and Short-Term Investments1.87B1.74B1.65B703.65M637.80M521.43M
Total Debt1.27B1.56B1.40B1.45B2.07B2.04B
Total Liabilities2.69B2.63B2.28B2.35B3.11B3.11B
Stockholders Equity5.57B5.25B5.04B3.73B3.56B3.14B
Cash Flow
Free Cash Flow559.58M814.73M266.97M881.22M342.01M105.67M
Operating Cash Flow960.24M1.22B546.06M1.15B679.77M355.34M
Investing Cash Flow-371.75M-484.99M-284.74M-254.36M-299.55M-331.05M
Financing Cash Flow-476.56M-730.41M657.94M-783.97M-232.50M-115.36M

Taiwan Hopax Chemicals Manufacturing Co. Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:6509 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:6509TW:650972OutperformTWD 9.02B12.96―3.23%2.00%57.23%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TW:3708TW:370849NeutralTWD 8.37B2.73―6.94%-79.42%2756.52%
TW:4739TW:473946NeutralTWD 8.41B13.42―1.41%98.05%725.72%
TW:4306TW:430644NeutralTWD 9.28B15.44―4.96%4.17%151.80%
TW:4989TW:498941NeutralTWD 10.18B-37.53――63.30%87.48%

* General Sector Average

Performance Comparison

0%100%200%300%TW:6509TW:3708TW:4306TW:4739TW:4989TW:7763Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:6509 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:6509Taiwan Hopax Chemicals Manufacturing Co. Ltd.43.2010.9433.93%
TW:3708Swancor Holding Co., Ltd.93.60-27.17-22.50%
TW:4306Yem Chio Co., Ltd.14.101.269.80%
TW:4739Coremax Corporation71.00-0.53-0.74%
TW:4989LCY Technology Corp.60.9013.3928.18%
TW:7763Johnson Fine Chemical Co Ltd141.5066.6689.07%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026